FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2331704598> ?p ?o ?g. }

• W2331704598 abstract "Persistent STAT3 signaling contributes to malignant progression in many diverse human tumors. STAT3 has been found to be constitutively active in activated B cell (ABC)-like diffuse large B cell lymphomas (DLBCL). We investigated the effect of STAT3 silencing in human DLBCL Ly3 cells both in vitro and in vivo. For this purpose, we established stably transduced STAT3 shRNA-expressing lentivirus Ly3 cells and control lentivirus Ly3 cells. The stable expression of STAT3 shRNA resulted in 40-50% reduction of STAT3 protein levels compared to the control cells. In vitro experiments revealed that STAT3 downregulation was associated with a higher percentage of dead cells in STAT3 shRNA cells compared with the control cells, and this percentage was even higher in serum starvation conditions. STAT3 silencing resulted in inhibition of IL-10-inducible upregulation of c-Myc associated with downregulation of IL-10-dependent STAT3 activation and inhibition of IL-10-inducible cell growth. STAT3 inhibition also reduced adhesion to the bone marrow stroma layer and migration toward SDF-1 alpha. Moreover, analysis of inflammatory cytokines and receptors indicated a substantial downregulation of CXCL6 mRNA levels in STAT3 shRNA cells compared to the control cells. Tumors in control Ly3-bearing mice grew progressively, whereas tumors in STAT3 shRNA Ly3-bearing mice regressed 4-5 days after injection. This tumor regression was associated with Caspase-3-dependent apoptosis and significant reduction of STAT3 target genes at the protein level such as Mcl-1, c-Myc and Survivin. Moreover, immunofluorescence analysis of tumor specimens showed that while granulocytes and endothelial cells infiltrated into the control cells-bearing tumors, tumor bearing STAT3 shRNA cells showed less or no infiltration of these cells. We also observed reduction of IL-10 production and the secretion of other cytokines was altered as well. Thus, our results show that even partial down-regulation of STAT3 could achieve complete suppression of the tumorigenesis of ABC-like DLBCL Ly3 cells by affecting also the tumor microenvironment. Furthermore, we tested two STAT3 inhibitors, STATTIC and S31-201, in this system. The viability of Ly3 cells grown in vitro was reduced by both compounds tested in a dose-dependent manner and the antiproliferative effect was associated with inhibition of STAT3 phosphorylation. The antilymphoma activity of STATTIC was also observed in vivo. This is the first demonstration in vivo that direct STAT3 inhibition in ABC-like DLBCL suppresses tumor growth. While developing a small-molecule STAT3 inhibitor as well as siRNA delivery for clinical trials is still a challenge, our studies validate STAT3 as a good target for therapy in DLBCL and also establish that STAT3 siRNA-based gene therapy is a feasible approach for DLBCL. In Sum, our data support continued development of new STAT3 inhibitors as well as STAT3 siRNA delivery strategies for treatment of DLBCL. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 1637. doi:10.1158/1538-7445.AM2011-1637" @default.
• W2331704598 created "2016-06-24" @default.
• W2331704598 creator A5012334511 @default.
• W2331704598 creator A5022795218 @default.
• W2331704598 creator A5023734653 @default.
• W2331704598 creator A5025245155 @default.
• W2331704598 creator A5039374832 @default.
• W2331704598 creator A5049139228 @default.
• W2331704598 creator A5053275663 @default.
• W2331704598 creator A5055800058 @default.
• W2331704598 creator A5059829647 @default.
• W2331704598 creator A5065487922 @default.
• W2331704598 date "2011-04-15" @default.
• W2331704598 modified "2023-09-27" @default.
• W2331704598 title "Abstract 1637: STAT3 as a new molecular target for treating ABC-like DLBCL" @default.
• W2331704598 doi "https://doi.org/10.1158/1538-7445.am2011-1637" @default.
• W2331704598 hasPublicationYear "2011" @default.
• W2331704598 type Work @default.
• W2331704598 sameAs 2331704598 @default.
• W2331704598 citedByCount "0" @default.
• W2331704598 crossrefType "proceedings-article" @default.
• W2331704598 hasAuthorship W2331704598A5012334511 @default.
• W2331704598 hasAuthorship W2331704598A5022795218 @default.
• W2331704598 hasAuthorship W2331704598A5023734653 @default.
• W2331704598 hasAuthorship W2331704598A5025245155 @default.
• W2331704598 hasAuthorship W2331704598A5039374832 @default.
• W2331704598 hasAuthorship W2331704598A5049139228 @default.
• W2331704598 hasAuthorship W2331704598A5053275663 @default.
• W2331704598 hasAuthorship W2331704598A5055800058 @default.
• W2331704598 hasAuthorship W2331704598A5059829647 @default.
• W2331704598 hasAuthorship W2331704598A5065487922 @default.
• W2331704598 hasConcept C104317684 @default.
• W2331704598 hasConcept C119056186 @default.
• W2331704598 hasConcept C127561419 @default.
• W2331704598 hasConcept C153911025 @default.
• W2331704598 hasConcept C173396325 @default.
• W2331704598 hasConcept C190232843 @default.
• W2331704598 hasConcept C190283241 @default.
• W2331704598 hasConcept C2775975398 @default.
• W2331704598 hasConcept C502942594 @default.
• W2331704598 hasConcept C55493867 @default.
• W2331704598 hasConcept C86803240 @default.
• W2331704598 hasConceptScore W2331704598C104317684 @default.
• W2331704598 hasConceptScore W2331704598C119056186 @default.
• W2331704598 hasConceptScore W2331704598C127561419 @default.
• W2331704598 hasConceptScore W2331704598C153911025 @default.
• W2331704598 hasConceptScore W2331704598C173396325 @default.
• W2331704598 hasConceptScore W2331704598C190232843 @default.
• W2331704598 hasConceptScore W2331704598C190283241 @default.
• W2331704598 hasConceptScore W2331704598C2775975398 @default.
• W2331704598 hasConceptScore W2331704598C502942594 @default.
• W2331704598 hasConceptScore W2331704598C55493867 @default.
• W2331704598 hasConceptScore W2331704598C86803240 @default.
• W2331704598 hasLocation W23317045981 @default.
• W2331704598 hasOpenAccess W2331704598 @default.
• W2331704598 hasPrimaryLocation W23317045981 @default.
• W2331704598 hasRelatedWork W1592989792 @default.
• W2331704598 hasRelatedWork W1843009062 @default.
• W2331704598 hasRelatedWork W2048675139 @default.
• W2331704598 hasRelatedWork W2057868683 @default.
• W2331704598 hasRelatedWork W2059886311 @default.
• W2331704598 hasRelatedWork W2275941144 @default.
• W2331704598 hasRelatedWork W2312305068 @default.
• W2331704598 hasRelatedWork W2323360903 @default.
• W2331704598 hasRelatedWork W2326138875 @default.
• W2331704598 hasRelatedWork W2329142505 @default.
• W2331704598 hasRelatedWork W2572601061 @default.
• W2331704598 hasRelatedWork W2791755500 @default.
• W2331704598 hasRelatedWork W2886887482 @default.
• W2331704598 hasRelatedWork W2896285889 @default.
• W2331704598 hasRelatedWork W2945326378 @default.
• W2331704598 hasRelatedWork W2995571090 @default.
• W2331704598 hasRelatedWork W3112772741 @default.
• W2331704598 hasRelatedWork W3143887715 @default.
• W2331704598 hasRelatedWork W3190501804 @default.
• W2331704598 hasRelatedWork W3213925840 @default.
• W2331704598 isParatext "false" @default.
• W2331704598 isRetracted "false" @default.
• W2331704598 magId "2331704598" @default.
• W2331704598 workType "article" @default.